From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 5,042,000 shares, representing 5.02% for $249.18 million under the buyback announced on March 12, 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.2 USD | +0.09% | -0.17% | +24.23% |
05-29 | BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating | MT |
05-20 | Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.23% | 8.93B | |
-5.17% | 184B | |
-0.18% | 107B | |
-4.04% | 67.9B | |
-5.55% | 46.49B | |
+12.06% | 45.81B | |
+7.40% | 42.55B | |
+20.33% | 30.78B | |
+14.24% | 26.11B | |
-3.89% | 23.9B |
- Stock Market
- Equities
- GMED Stock
- News Globus Medical, Inc.
- Tranche Update on Globus Medical, Inc.'s Equity Buyback Plan announced on March 12, 2020.